Quantcast
Viewing all articles
Browse latest Browse all 24331

Wright Medical Group Reaches Financial Agreement With BioMimetic’s CEO

Medical device maker Wright Medical Group has agreed to buy BioMimetic Therapeutics for $380 million and has reached a financial agreement with Sam Lynch, MD, BioMimetic CEO, according to the Nashville Business Journal.
Dr. Lynch will receive a $1.25 million bonus for work related to the augment bone graft device. He will also receive $160,275 for unused vacation and $261,632 as a bonus for the year.

More Articles on Devices:
Ohio Third Frontier Gives $3M to Medical Device Partnership Fund
Dr. Paul Sawin Performs First Spine Surgery With PCM Cervical Disc
9 Orthopedic Devices Launched, Cleared in December


Viewing all articles
Browse latest Browse all 24331

Trending Articles